New diabetes drug proving helpful

According to recent news reports, Sanofi-Aventis diabetes drug Acomplia could help to improve blood sugar control amongst patients suffering from type 2 diabetes who are failing to control their condition using insulin therapy.
Sanofi, a French pharmaceutical company, have defended the drug following rejection as a weight loss treatment in America. The Food and Drug Administration rejected the drug due to fears that it could provoke suicidal thoughts.
Acomplia has faced a rocky road after clinical trials apparently revealed increased likelihood of anxiety and depression as side effects from weight loss treatment. Sanofi, who had hoped that the drug would become a blockbuster, are now seeking to reposition it as a type 2 diabetes drug. Trial data show it could help diabetics to achieve their HbA1c goals.